Advanz Pharma Specialty Medicine Switzerland GmbH
Advanz Pharma Specialty Medicine Switzerland GmbH is a Originators company based in Zürich (Zurich) recorded by Swissmedic as the authorisation holder for 21 human medicines. That places it 88 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Zürich |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 21 |
| Founded | Not available |
| Employees | 1-10 |
| Parent group | ADVANZ PHARMA |
| Activity | Not available |
| Website | advanzpharma.com |
Medicines authorised in Switzerland
Advanz Pharma Specialty Medicine Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 21 human medicines. The table shows 21 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
21 of 21 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Androcur Depot | 40881 | B | G03HA01 | 1977-11-09 |
| Androcur-50 | 37482 | B | G03HA01 | 1972-10-13 |
| Diamox | 21191 | B | S01EC01 | 1955-08-24 |
| Diamox | 22002 | B | S01EC01 | 1955-12-24 |
| Eribulin Advanz Pharma 0.44 mg/ml | 69924 | A | L01XX41 | 2025-06-26 |
| Erythrocin i.v. | 20258 | B | J01FA01 | 1957-09-23 |
| Erythrocin-ES 500 | 47322 | B | - | 1986-06-06 |
| Fucithalmic | 48165 | A | S01AA13 | 1988-11-15 |
| Furadantin retard | 34921 | B | J01XE01 | 1969-08-06 |
| Gobivaz 100 mg/1 ml | 70709 | B | L04AB06 | 2026-07-30 |
| Gobivaz 100 mg/1 ml | 70711 | B | L04AB06 | 2026-07-30 |
| Hytrin BPH 1 mg und 2 mg | 52342 | B | G04CA03 | 1994-10-21 |
| Lanreotid Advanz Pharma 60 mg | 70157 | A | H01CB03 | 2026-08-18 |
| Mynzepli 40 mg/ml | 70617 | B | S01LA05 | 2026-05-13 |
| Mynzepli 40 mg/ml | 70618 | B | S01LA05 | 2026-05-13 |
| Nootropil | 54650 | B | - | 2005-04-21 |
| Nootropil 800 mg | 40502 | B | N06BX03 | 1977-04-13 |
| Néo-Mercazole | 21037 | B | H03BB01 | 1955-01-13 |
| Testoviron Depot 250 mg | 17626 | B | G03BA03 | 1952-07-09 |
| Testoviron Depot 250 mg/ml | 70090 | B | G03BA03 | 2026-05-11 |
| Zevtera | 65089 | A | J01DI01 | 2014-12-23 |
Frequently asked questions
How many medicines does Advanz Pharma Specialty Medicine Switzerland GmbH have authorised in Switzerland?
Advanz Pharma Specialty Medicine Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 21 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Advanz Pharma Specialty Medicine Switzerland GmbH based?
The Swiss location recorded for Advanz Pharma Specialty Medicine Switzerland GmbH is Zürich, Zurich.
Is Advanz Pharma Specialty Medicine Switzerland GmbH a Swissmedic authorisation holder?
Yes. Advanz Pharma Specialty Medicine Switzerland GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.